Subsequently, we evaluated the pharmacological effect of ATX, a non-stimulant drug available for ADHD and/or ASD patients, on the behavioral deficits of Ptchd1 KO mice. This evidence concerns the gene PTCHD1 and attention deficit-hyperactivity disorder.